Sorfequiline-based treatment for new drug-sensitive TB
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests a new medicine called sorfequiline, given in a combination regimen, to treat adults with drug-sensitive TB. It aims to see if sorfequiline can work as well as or better than standard treatment and shorten the time to cure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of TB that is sensitive to the standard antibiotics (rifampin and isoniazid), or you were cured of TB before and haven't had treatment for at least 3 years.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control during the study.
- You weigh at least 35 kilograms (about 77 pounds).
- You do not have TB that has spread outside your lungs (extrapulmonary TB).
- You do not have a serious heart condition or take medicines that affect your heart's rhythm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized treatment approach for people with rifampicin-resistant TB that is still sensitive to fluoroquinolones. It aims to find the best combination of medicines based on your specific TB profile.
This study is testing new combinations of drugs to treat tuberculosis (TB) in the lungs. It aims to find a more effective and shorter treatment, and you may benefit from receiving these new drugs while helping advance TB research.
This trial tests a shorter course of three drugs (bedaquiline, moxifloxacin, and pyrazinamide) for people with newly diagnosed, drug-sensitive TB. It aims to see how quickly the drugs kill the bacteria in the first few days of treatment.
This study tests whether adding sitafloxacin to certain short tuberculosis (TB) treatment plans can cure TB faster while staying safe. You may be eligible if you have drug-susceptible lung TB and your TB bacteria are sensitive to several specific TB medicines.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This trial tests a shorter treatment for drug-resistant tuberculosis (TB) using the medicine Pretomanid. It aims to find a more manageable cure for people whose TB does not respond to the standard first-line drug, rifampicin.
Hear when a new Tuberculosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.